Biggest News Aggregation in the World
📰 Launch Products News

Page 2 - Launch Products News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Launch Products. Real-time updates on events, politics, business and more.

Takeda Pharmaceutical Company Limited: Takeda Reinforces Long-term Growth Through Pipeline Advancement and Two Targeted Acquisitions; Delivers Another Strong Quarter in FY2022 Q3

Announced Agreement With Nimbus Therapeutics in December to Acquire a Potential Best-in-Class TYK2 Inhibitor, and with HUTCHMED in January to In-license Highly Selective, Oral Tyrosine Kinase Inhibitor
United States Hong Kong Brendan Jennings Schwierige Zeiten Christopher Oreilly International Financial Reporting Standards

Takeda Reinforces Long-term Growth Through Pipeline Advancement and Two Targeted Acquisitions; Delivers Another Strong Quarter in FY2022 Q3

Announced Agreement With Nimbus Therapeutics in December to Acquire a Potential Best-in-Class TYK2 Inhibitor, and with HUTCHMED in January to In-license Highly Selective, Oral Tyrosine Kinase... | February 2, 2023
United States Hong Kong International Financial Reporting Standards European Commission Arrowhead Pharmaceuticals Inc Exchange Commission

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Takeda Delivers Strong FY2021 Results; Continued Growth Momentum Expected in FY2022

11.05.2022 - Takeda (TOKYO:4502/NYSE:TAK) today announced strong financial results for fiscal year 2021 (period ended March 31, 2022), driven by the performance of its growth products, new product launches and strength across its key business areas. Takeda ...
United States Nordrhein Westfalen Exchange Commission Federal Reserve Bank International Financial Reporting Standards Japan Ministry Of Health

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science